Fundraising Fox

Faze Medicines

Cambridge, US · Founded 2018 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

CP
Cary PfefferExecutive Officer, Director
EF
Ed FreedmanExecutive Officer, Director
RT
Robert TepperDirector
CH
Charles HomcyDirector

Investors · 1

Third Rock Venturesreported · 2 sourcesBoston · $100K – $5Mvia Charles Homcy · board

Reported raises · per SEC filings

Form D private placements
▶$30.4MraisedDec 2020 · 9 investors · Biotechnology
Rule 506(b)
Faze Medicines secures funding to study molecular condensates in ALSpadiracinnovation.org · Dec 2020
Officers, directors & promoters on the filing
  • Cary PfefferExecutive Officer, Director
  • Ed FreedmanExecutive Officer, Director
  • Robert TepperDirector
  • Charles HomcyDirector
Offering amount
$81M
Amount sold
$30.4M
First sale
Dec 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news